Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review

被引:0
作者
Li, Yimeng [1 ]
Hsu, Sylvia H. [2 ]
Wang, Rong [1 ]
Theprungsirikul, Poy [3 ]
Neparidze, Natalia [3 ]
Chang, Su-Hsin [4 ]
Wang, Shi-Yi [1 ]
机构
[1] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, 60 Coll St,POB 208034, New Haven, CT 06520 USA
[2] York Univ, Schulich Sch Business, Toronto, ON, Canada
[3] Yale Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06520 USA
[4] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO USA
关键词
BMI; Obesity; Systematic review; Gender; Race; TERM-FOLLOW-UP; NEWCASTLE-OTTAWA SCALE; BODY-MASS INDEX; MALIGNANT-TRANSFORMATION; LONG-TERM; SIGNIFICANCE MGUS; RISK; QUALITY; PREVALENCE; PROGNOSIS;
D O I
10.1016/j.clml.2024.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS) is a pre-malignant condition of multiple myeloma (MM). Evidence suggested old age, black race, male gender, and obesity as risk factors for MGUS development; however, whether they are associated with an increased risk of progression to MM among patients with MGUS is unclear. A systematic search of PUBMED and EMBASE for cohort studies investigating the association between age/race/gender/obesity and progression to MM. We used the Newcastle-Ottawa Scale (NOS) to assess the methodologic quality of the included studies. Summary risk ratios were calculated using random-effects models. We identified 24 publications, of which 17 articles were included in the main analyses. Overall, the quality of the studies was fair (mean NOS = 5.5). Our meta-analyses showed that old age was positively associated with the risk of the MGUS-MM progression (risk ratio: 2.38; 95% confidence interval [CI] 1.59-3.57), while race was not statistically significantly associated with the risk (blacks vs whites: 1.09; 95% CI: 0.77-1.54). Males had a lower risk of MGUS-MM progression, compared to females (risk ratio: 0.70; 95% CI 0.50-1.0; P -value = .048). High body mass index was significantly associated with an increased risk of MGUS-MM progression (risk ratio: 1.32; 95% CI 1.12-1.57). Based on extant research, old age, female sex, and obesity may be implicated in MGUS-MM progression. However, several studies which found an insignificant association between age/gender and progression did not report the risk estimates. Publication bias exists and our risk estimates may be overestimated. More studies are warranted to confirm our findings.
引用
收藏
页码:e222 / e231
页数:10
相关论文
共 54 条
  • [1] Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy
    Baldini, L
    Guffanti, A
    Cesana, BM
    Colombi, M
    Chiorboli, O
    Damilano, I
    Maiolo, AT
    [J]. BLOOD, 1996, 87 (03) : 912 - 918
  • [2] Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit
    Bumma, Naresh
    Nagasaka, Misako
    Hemingway, Griffin
    Miyashita, Hirotaka
    Chowdhury, Tahmida
    Kim, Seongho
    Vankayala, Hema M.
    Ahmed, Shabbir
    Jasti, Pallavi
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05) : 305 - 311
  • [3] Cancer Statistics Center, Am. Cancer Soc
  • [4] Multi-trajectory models of serum biomarkers among patients with monoclonal gammopathy of undetermined significance
    Castaneda-Avila, Maira A.
    Lapane, Kate L.
    Person, Sharina D.
    Zhou, Yanhua
    Gurwitz, Jerry
    Mazor, Kathleen M.
    Epstein, Mara M.
    [J]. HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 409 - 416
  • [5] Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
    Cesana, C
    Klersy, C
    Barbarano, L
    Nosari, AM
    Crugnola, M
    Pungolino, E
    Gargantini, L
    Granata, S
    Valentini, M
    Morra, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1625 - 1634
  • [6] Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study
    Chang, Su-Hsin
    Luo, Suhong
    Thomas, Theodore S.
    O'Brian, Katiuscia K.
    Colditz, Graham A.
    Carlsson, Nils P.
    Carson, Kenneth R.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05):
  • [7] Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Chang, Vicky C.
    Khan, Ali A.
    Huang, Wen-Yi
    Katki, Hormuzd A.
    Purdue, Mark P.
    Landgren, Ola
    Hofmann, Jonathan N.
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [8] It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma
    Choa, Ruth
    Panaroni, Cristina
    Bhatia, Roma
    Raje, Noopur
    [J]. BLOOD ADVANCES, 2023, 7 (18) : 5510 - 5523
  • [9] Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review
    Cosemans, Charlotte
    Oben, Benedith
    Arijs, Ingrid
    Daniels, Annick
    Declercq, Jeroen
    Vanhees, Kimberly
    Froyen, Guy
    Maes, Brigitte
    Mebis, Jeroen
    Rummens, Jean-Luc
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04) : 235 - 248
  • [10] Cowan A, 2023, Lancet Haematol, V10, P203